ICICI Prudential Mutual Fund
| Instrument | Industry / rating | Quantity | Value (₹ Cr) | % to NAV |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd.SUNPHARMA | Pharmaceuticals & Biotechnology | 1.64 L | 32.57 | 20.76% |
| Divi's Laboratories Ltd.DIVISLAB | Pharmaceuticals & Biotechnology | 19,688 | 18.64 | 11.88% |
| Cipla Ltd.CIPLA | Pharmaceuticals & Biotechnology | 87,200 | 12.29 | 7.83% |
| Laurus Labs Ltd.LAURUSLABS | Pharmaceuticals & Biotechnology | 60,292 | 11.55 | 7.36% |
| Torrent Pharmaceuticals Ltd.TORNTPHARM | Pharmaceuticals & Biotechnology | 22,724 | 11.51 | 7.34% |
| Dr. Reddy's Laboratories Ltd.DRREDDY | Pharmaceuticals & Biotechnology | 94,471 | 10.91 | 6.95% |
| Lupin Ltd.LUPIN | Pharmaceuticals & Biotechnology | 37,631 | 8.24 | 5.25% |
| Aurobindo Pharma Ltd.AUROPHARMA | Pharmaceuticals & Biotechnology | 42,891 | 7.36 | 4.69% |
| Glenmark Pharmaceuticals Ltd.GLENMARK | Pharmaceuticals & Biotechnology | 23,325 | 5.78 | 3.69% |
| Alkem Laboratories Ltd.ALKEM | Pharmaceuticals & Biotechnology | 9,056 | 4.83 | 3.08% |
| Biocon Ltd.BIOCON | Pharmaceuticals & Biotechnology | 1.11 L | 4.56 | 2.9% |
| Zydus Lifesciences Ltd.ZYDUSLIFE | Pharmaceuticals & Biotechnology | 38,768 | 4.5 | 2.87% |
| IPCA Laboratories Ltd.IPCALAB | Pharmaceuticals & Biotechnology | 21,518 | 4.25 | 2.71% |
| Mankind Pharma Ltd.MANKIND | Pharmaceuticals & Biotechnology | 17,534 | 4.24 | 2.7% |
| Gland Pharma Ltd.GLAND | Pharmaceuticals & Biotechnology | 12,341 | 3.56 | 2.27% |
| Sai Life Sciences Ltd.SAILIFE | Pharmaceuticals & Biotechnology | 21,374 | 3.12 | 1.99% |
| Wockhardt Ltd.WOCKPHARMA | Pharmaceuticals & Biotechnology | 12,788 | 2.41 | 1.54% |
| Ajanta Pharma Ltd.AJANTPHARM | Pharmaceuticals & Biotechnology | 6,516 | 2.35 | 1.5% |
| Piramal Pharma Ltd.PPLPHARMA | Pharmaceuticals & Biotechnology | 96,391 | 2.07 | 1.32% |
| Abbott India Ltd.ABBOTINDIA | Pharmaceuticals & Biotechnology | 795 | 2.06 | 1.31% |
| TREPS | — | — | 1.69 | 1.07% |
| Net Current Assets | — | — | -1.58 | -1.01% |
Percentages are the AMC’s own filed figures. Rows without a ticker are instruments outside the listed equity universe — government securities, money-market paper, TREPS and net receivables — and are kept so the portfolio still totals 100%.